tiprankstipranks
Trending News
More News >
Lumibird SA (FR:LBIRD)
:LBIRD
Advertisement

Lumibird SA (LBIRD) AI Stock Analysis

Compare
3 Followers

Top Page

FR:LBIRD

Lumibird SA

(LSE:LBIRD)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 4o)
Rating:57Neutral
Price Target:
€16.50
▼(-19.51% Downside)
Lumibird SA's overall stock score is primarily influenced by its strong operational efficiency and moderate financial stability. However, bearish technical indicators and a high P/E ratio suggest caution. The lack of earnings call data and corporate events limits additional insights.

Lumibird SA (LBIRD) vs. iShares MSCI France ETF (EWQ)

Lumibird SA Business Overview & Revenue Model

Company DescriptionLumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser diodes, fiber lasers, fiber amplifiers and components, photonics solutions for time-of-flight lidar and range-finding, and doppler lidar systems for wind measurement. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The Medical division provides medical and ophthalmological solutions from diagnosis to laser treatment. The company was founded in 1970 and is headquartered in Lannion, France.
How the Company Makes MoneyLumibird generates revenue through multiple key streams, primarily from the sale of its laser systems and components across various sectors. The company earns significant income from long-term contracts with industrial clients, where it provides tailored laser solutions for applications like cutting, welding, and marking. Additionally, Lumibird has established partnerships with medical device manufacturers, supplying advanced laser technology for surgical and therapeutic applications. Other revenue streams include maintenance services, training, and consulting for clients, which further solidify its earnings. The company also benefits from government contracts and research grants aimed at advancing photonics technology, contributing to its overall financial performance.

Lumibird SA Financial Statement Overview

Summary
Lumibird SA demonstrates strong operational efficiency and moderate financial stability. Despite some pressure on margins, the company maintains a healthy equity ratio. Positive cash flows highlight its capability to support operations and growth, although improvements in profit margins and debt management are desirable.
Income Statement
75
Positive
Lumibird SA's income statement shows a stable revenue base with a slight increase from 2023 to 2024. Gross profit margin has slightly decreased over the years, indicating rising costs or pricing pressure. The net profit margin has declined from 2023 to 2024, suggesting challenges in maintaining profitability. However, EBIT and EBITDA margins remain decent, reflecting operational efficiency in managing expenses.
Balance Sheet
70
Positive
The balance sheet of Lumibird SA reflects moderate financial stability. The debt-to-equity ratio is manageable, though it has slightly increased over the years, indicating a rising reliance on debt. The equity ratio is stable, ensuring a sound capital structure. Return on equity has decreased, which may concern investors regarding the effectiveness of equity use.
Cash Flow
80
Positive
Lumibird SA's cash flow statement indicates strong operating cash flows, showing the company's ability to generate cash from its core operations. The free cash flow has improved from previous years but remains a concern due to high capital expenditures. The operating cash flow to net income ratio is robust, reflecting efficient cash generation relative to net income.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue210.06M206.55M190.96M162.47M126.73M
Gross Profit16.06M128.11M15.36M18.49M13.24M
EBITDA31.03M27.31M32.09M31.81M17.96M
Net Income5.70M7.13M11.35M13.86M5.64M
Balance Sheet
Total Assets429.80M405.25M372.04M347.62M305.43M
Cash, Cash Equivalents and Short-Term Investments71.14M56.20M61.68M97.13M80.33M
Total Debt161.06M145.08M114.18M112.03M88.31M
Total Liabilities231.79M211.95M174.86M162.51M138.05M
Stockholders Equity198.01M193.30M193.44M181.33M164.09M
Cash Flow
Free Cash Flow11.41M-4.89M-28.02M6.47M747.00K
Operating Cash Flow34.37M20.67M1.43M26.57M13.12M
Investing Cash Flow-22.84M-46.15M-29.34M-28.63M-67.14M
Financing Cash Flow3.39M21.69M-7.89M18.20M84.76M

Lumibird SA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price20.50
Price Trends
50DMA
18.41
Positive
100DMA
16.94
Positive
200DMA
13.09
Positive
Market Momentum
MACD
0.54
Negative
RSI
66.34
Neutral
STOCH
77.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LBIRD, the sentiment is Positive. The current price of 20.5 is above the 20-day moving average (MA) of 17.93, above the 50-day MA of 18.41, and above the 200-day MA of 13.09, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 66.34 is Neutral, neither overbought nor oversold. The STOCH value of 77.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LBIRD.

Lumibird SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
355.07M11.9711.41%2.16%-1.89%-3.39%
67
Neutral
244.99M8.776.73%3.19%-4.89%
57
Neutral
€443.83M42.085.51%5.66%66.79%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:LBIRD
Lumibird SA
20.50
12.00
141.18%
GB:0RUJ
Delta Plus
47.50
-18.16
-27.66%
GB:0NA0
EXEL INDUSTRIES
36.80
-8.52
-18.80%
GB:0NB0
Gerard Perrier Industrie
81.40
-4.38
-5.11%
DE:ZEP2
Eurofins-Cerep SA
DE:0DL
Biosynex SA
1.17
-2.25
-65.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 05, 2025